Heart Disease Clinical Trials in Seattle

Showing 21-40 of 117 trials

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

NCT04738474

The purpose of this study is to evaluate the feasibility and preliminary efficacy of the Promoting Resilience in Stress Management (PRISM) intervention in patients with adult congenital heart disease.

Congenital Heart Disease

University of Washington78 participantsStarted Mar 2023

Seattle, Washington, United States

RECRUITINGPHASE3< 1 mile

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT06898515

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

Acute Decompensated Heart Failure

Reprieve Cardiovascular, Inc400 participantsStarted Jul 2025

Irvine, California, United States • La Jolla, California, United States • Sacramento, California, United States +50 more locations

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Heart Disease Trials in Other Cities

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

SyncAV Post-Market Trial

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Hybrid Coronary Revascularization Trial

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Study of JK07 in Patients With Chronic Heart Failure

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Global Utilization And Registry Database for Improved heArt preservatioN

Other Conditions in Seattle